STUDIEN-SAMMLUNG

Konjugierte Linolsäuren (23 Studien)

23. Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am. J. Clin. Nutr. 91 (2010) 175 – 183 (2010)
22. Supplementation with CLA: Isomer incorporation into serum lipids and effects on body fat of women. Lipids 38 (2003) 805 - 811 (2003)
21. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25 (2002) 1516 - 1521 (2002)
20. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 106 (2002) 1925 - 1929 (2002)
19. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25 (2002) 1516 - 1521 (2002)
18. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1129 - 1135 (2001)
17. Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function. Lipid 36 (2001) 669 - 774 (2001)
16. The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 36 (2001) 221 - 227 (2001)
15. Conjugated linoleic acid supplementation in humans - metabolic effects. Lipids 36 (2001) 772 - 782 (2001)
14. Conjugated linoleic acid supplementation in humans: effects on fatty acid and glycerol kinetics. Lipids 36 (2001) 767 - 772 (2001)
13. Conjugated linoleic acid supplementation in humans: metabolic effects. Lipids 36 (2001) 773 – 781 (2001)
12. Conjugated linoleic acid supplementation in humans: effects on fatty acid and glycerol kinetics. Lipids 36 (2001) 767 – 772 (2001)
11. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35 (2000) 777 - 782 (2000)
10. Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids 35 (2000) 1065 - 1071 (2000)
9. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res. 1426 - 1433 (1999) (1999)
8. Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J. Bone Miner. Res. 14 (1999) 1153 - 1162 (1999)
7. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. BBRC 244 (1998) 678 - 682 (1998)
6. Effect of conjugated linoleic acid on body composition in mice. Lipids 32 (1997) 853 - 858 (1997)
5. The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Letters 116 (1997) 121 - 130 (1997)
4. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108 (1994) 19 - 25 (1994)
3. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 54 (1994) 1212 - 1215 (1994)
2. Differential stimulatory and inhibitory responses of human MCF-7 breast cancer cells to linoleic acid and conjugated linoleic acid in culture. Anticancer Res. 12 (1992) 2143 - 2146 (1992)
1. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and b-carotene on the in vitro growth of human cancer cells. Cancer Letters 63 (1992) 125 - 133 (1992)